AL AMYLOIDOSIS
Clinical trials for AL AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AL AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AL AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare amyloidosis: drug targets rogue cells in phase 2 trial
Disease control CompletedThis study tested a drug called belantamab mafodotin in 35 people with AL amyloidosis, a rare disease where abnormal proteins build up in organs. All participants had already received at least one prior treatment. The goal was to see if the drug could reduce or eliminate those ha…
Matched conditions: AL AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
One donor, two transplants: new hope for patients with blood cancer and kidney failure
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched family donor for 10 people with both a serious blood disorder and chronic kidney disease. The goal was to treat both conditions with one donor, potentially reducing the need for lifelong anti-…
Matched conditions: AL AMYLOIDOSIS
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Protein clues could predict amyloidosis onset
Knowledge-focused CompletedThis study followed 37 people with a genetic risk for hereditary ATTR amyloidosis over five years. Researchers measured a specific misfolded protein in the blood to see if it could signal when the disease starts or worsens. No treatments were tested; the goal was simply to learn …
Matched conditions: AL AMYLOIDOSIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 08:45 UTC
-
Heart scans may predict survival in rare amyloid disease
Knowledge-focused CompletedThis study looked at 30 people newly diagnosed with cardiac AL amyloidosis, a rare disease where abnormal proteins damage the heart. Researchers used advanced MRI, echocardiogram, and PET scans to see if these imaging tools could predict survival and measure how well chemotherapy…
Matched conditions: AL AMYLOIDOSIS
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 26, 2026 08:29 UTC